Chemistry Wealth Management LLC boosted its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 38.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,926 shares of the company’s stock after buying an additional 814 shares during the period. Chemistry Wealth Management LLC’s holdings in Colgate-Palmolive were worth $266,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the third quarter valued at approximately $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive in the third quarter valued at approximately $53,000. Prospera Private Wealth LLC acquired a new position in Colgate-Palmolive in the third quarter valued at approximately $64,000. True Wealth Design LLC lifted its holdings in Colgate-Palmolive by 1,460.9% in the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC lifted its holdings in Colgate-Palmolive by 93.4% in the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after buying an additional 368 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.37% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
View Our Latest Analysis on CL
Colgate-Palmolive Stock Up 0.3 %
Shares of CL stock opened at $88.79 on Friday. The firm has a fifty day moving average of $92.27 and a 200-day moving average of $97.78. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30. The company has a market capitalization of $72.55 billion, a price-to-earnings ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.25%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Using the MarketBeat Dividend Tax Calculator
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Low PE Growth Stocks: Unlocking Investment Opportunities
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.